To view this email as a web page, click here.
 
Inside Trump’s plan to lower drug prices
In his recent State of the Union address, President Donald Trump promised to continue lowering drug prices and fund research for HIV/AIDS and childhood cancer. Here are the ways experts say he will implement those pledges.
Read more
 
FDA cracks down on fake Alzheimer’s products
FDA is warning several companies that are illegally selling drugs and dietary supplements that the marketers claim can cure Alzheimer’s disease and other conditions.
Read more
 
Four biosimilar growth opportunities to watch
From our sister brand, Managed Healthcare Executive: The value and benefits of biosimilars are increasingly becoming more apparent. Here are four areas where they are growing the most.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.